OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CVAC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

CureVac (CVAC) Earnings Date & Reports

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVAC is expected to report earnings to fall 80.04% to -4 cents per share on August 14

Q2'25

Est.

$-0.05

Q1'25

Missed

by $0.07

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.10

Q2'24

Missed

by $0.04

The last earnings report on May 20 showed earnings per share of -23 cents, missing the estimate of -16 cents. With 259.11K shares outstanding, the current market capitalization sits at 1.22B.

View a ticker or compare two or three

Compare

CVAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CVAC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CVAC showed earnings on May 20, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Friedrich-Miescher-Strasse 15

Phone

+49 707198830

Employees

1049

Web

https://www.curevac.com